Shots:The EC has approved (under exceptional circumstances) Gohibic to treat SARS-CoV-2-induced acute respiratory distress syndrome (ARDS) adults on SoC (incl. systemic corticosteroids) & IMV (with/without ECMO) Approval was backed by results of the P-III (PANAMO) study assessing Gohibic vs. PBO among invasively mechanically ventilated COVID-19 patients in the ICU, which showed improvement in survival with…

THOUGHTSPOT

Recent Insights into Advances of COVID-19 Treatment

Introduction:The current century has witnessed the universal spread of the unknown species of coronaviruses. The rapid deterioration of the public health system with changes in ecology and urbanization has accelerated more recurrent epidemics, which become more troublesome to prevent and contain promptly. A novel coronavirus (CoV) emerged in December 2019, is associated with respiratory…

ByParshuram NivruttiMay 27, 2021

InflaRx’s Gohibic (Vilobelimab) Receives the EC Approval for the Treatment of ARDS

Recent Insights into Advances of COVID-19 Treatment

Contact US

OUR INFORMATION

FOLLOW US